ACS Omega · 2023 · 13 citations · 9 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsHeterocyclic ChemistryLead Compound DesignQuantitative Structure-activity RelationshipsStructure-activity Relationship AnalysisAntiproliferative AgentsAntiproliferative Drug ActionChemical Structure-activity RelationshipsChemical Synthesis Of AnaloguesHalf-maximal Inhibitory ConcentrationMedicinal Chemistry ApplicationsPyrazole ChemistryPyrazole Synthesis
High Resolution Image Download MS PowerPoint Slide Pyrazole and sulfonamide constitute an important class of drugs, with several types of pharmacological agents. Facile synthesis of two new series of 3,5-dimethyl-1 H -pyrazole-4-sulfonamide and 1,3,5-trimethyl-1 H -pyrazole-4-sulfonamide derivatives was designed and synthesized. These pyrazole-4-sulfonamide derivatives are characterized by Fourier transform infrared (FT-IR), 1 H NMR, 13 C NMR, and elemental analysis, and their biological evolution data are presented. This paved way for the development of new pyrazole-4-sulfonamide derivatives. These compounds are tested for their in vitro antiproliferative activity against U937 cells by the CellTiter-Glo Luminescent cell viability assay using Mitomycin C. Cytotoxicity detection is based on the measurement of LDH activity, while these compounds did not exhibit cytotoxic activity on these cells. Half maximal inhibitory concentration (IC 50 ) was calculated by Graph Pad Prism software for each dose. Their structure–activity relationships were obtained and discussed.
9
Thomas Decker, Marie‐Luise Lohmann‐Matthes · Journal of Immunological Methods · 1988 · 1.4K citations
Review: biologically active pyrazole derivatives
Anam Ansari, Abad Ali, Mohd Asif et al. · New Journal of Chemistry · 2016 · 767 citations
Yuhong Ju, Rajender S. Varma · The Journal of Organic Chemistry · 2005 · 313 citations